When a patient presents with classic symptoms of low progesterone, the standard clinical response is to supplement. But what happens when their labs look perfect, the dosage is adequate, and yet… they still aren’t getting better?

Join us for this webinar as we look beyond serum levels and dive into the physiological roadblocks that cause progesterone therapy to fail. You will learn how to identify the hidden drivers of receptor impairment and discover actionable strategies to restore cellular sensitivity.

What You’ll Take Away

In this session, we break down the mechanics of patient acquisition and conversion. We focus on capitalizing on the leads you already have to build automated, trust-driven systems that convert cold inquiries into loyal patients.

You'll learn:

• Normal labs do not rule out resistance. Serum P4 can be adequate while tissue fails to respond. Receptor impairment and hormone deficiency are not the same problem, and treating them the same way produces incomplete results.

• Resistance has identifiable root causes. Estrogen dominance, xenoestrogen exposure, inflammation, thyroid dysfunction, gut dysbiosis, and cortisol excess all suppress progesterone receptor expression directly. The dose is not the problem if the receptor is the problem.

• Progesterone is both the therapy and part of the fix. Unlike insulin resistance, escalating P4 still helps. It is independently anti-inflammatory, downregulates estrogen receptors, and produces allopregnanolone without requiring PR signaling. More P4 plus root cause work is the full answer.